Reserved for Patrin Pharma

50% off the $29 audit or $99 Fix-It Kit. Use at checkout:

PATRINPHARMA50

⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

Patrin Pharma

Patrin Pharma

Unclaimed

AEO Score: 4/10

Crawled 1 times by AI engines

Claude

patrinpharma.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Patrin Pharma just got measured.

4/10 means Patrin Pharma is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About Patrin Pharma

Sales Partnering Contact High quality generic drugs, development to market Homepage Posted September 16th, 2012 by admin.

Key Topics

Homepage
Patrin Pharma management is pleased to announce an expansion by adding key individuals to its team by strengthening experts in the R&D and Sales team. In addition, the organization is adding another 4500 square foot facility into existing space making it over 18,000 square feet foot print within the greater Chicago area.
US FDA has approved Patrin Pharma’s generical niche product Calcitriol Oral Solution. Product will be launched shortly into US Market.
US FDA has approved Patrin Pharma’s generical product application A212604 for Pregabalin Oral Solution – a Schedule V drug. Product will be launched shortly into US Market.
Jay Trivedi is pleased to report that on March 8, 2021, Patrin Pharma entered into a confidential settlement agreement with Assertio Therapeutics.  On March 10, 2021, the Court granted the parties’ agreed motion for entry of Judgment and Order of Permanent Injunction. This settlement concludes all ongoing ANDA litigation relating to our ANDA for Diclofenac Potassium Powder for Oral Solution, 50mg.  Patrin will launch the product upon the agreed date in the settlement.
Patrin Pharma Inc Announces Successful Drug Application to FDA for Diclofenac Potassium Powder for Solution, 50 mg and Related News. Diclofenac Potassium Powder

Details

Industry: pharmaceuticals

Employees: 1-10

patrinpharma.com

AI Visibility Breakdown

1

Structured Data

4

Content Structure

6

Entity Clarity

6

E-E-A-T Signals

5

Technical AEO

2

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for Patrin Pharma: Tech & Electronics

Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?

Tech buyers are the most research-intensive shoppers on the internet.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Patrin Pharma.

Source & Attribution

Scored by Engagemii on June 20, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/patrinpharma

Cite this score: Engagemii (2026). "AEO Score for Patrin Pharma." Retrieved from https://engagemii.com/aeo/brands/patrinpharma

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform